What is the evidence basis for existing treatments of eating disorders?

Current Opinion in Pediatrics

Volumn 15, Issue 3, 2003, Pages 344-345

  Bergh, Cecilia ^a   Ejderhamn, Jan ^a   Södersten, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ANOREXIA NERVOSA; BULIMIA; DIETARY INTAKE; EATING DISORDER; EVIDENCE BASED MEDICINE; FEEDING BEHAVIOR; FOLLOW UP; FOOD INTAKE; HEAT; HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REMISSION; REVIEW; SATIETY; SOCIAL BEHAVIOR; TREATMENT PLANNING;

EATING DISORDERS; EVIDENCE-BASED MEDICINE; HUMANS;

EID: 0038289249     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200306000-00021     Document Type: Review

References (16)

1. Ben-Tovim DI, Walker K, Gilchrist P, et al.: Outcome in patients with eating disorders: a 5-year study. Lancet 2001, 357:1254-1257.
2. Eisler I, Dare C, Russell GF, et al.: Family and individual therapy in anorexia nervosa. A 5-year follow-up. Arch Gen Psychiatry 1997, 54:1025-1030.
3. Halmi KA, Agras WS, Mitchell J, et al.: Relapse predictors of patients with bulimia nervosa who achieved abstinence through cognitive behavioral therapy. Arch Gen Psychiatry 2002, 59:1105-1109.
4. Zwaan M, Roerig J: Pharmacological treatment. In: Evidence and Experience in Psychiatry, vol. 6. Eating disorders. Edited by Halmi K, Maj M. World Psychiatric Association series. New York: John Wiley & Sons; 2003: in press.
5. Lee MD, Kennett GA, Dourish CT, et al.: 5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253. Psychopharmacology 2002, 164:49-60.
6. Pinilla L, Gonzalez LC, Tena-Sempere M, et al.: 5-HT1 and 5-HT2 receptor activation reduces N-methyl-d-aspartate (NMDA)-stimulated LH secretion in prepubertal male and female rats. Eur J Endocrinol 2003, 148:121-127.
7. Rosen RC, Lane RM, Menza M: Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999, 19:67-85.
8. Ferguson CP, La Visa MC, et al.: Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa? Int J Eat Disord 1999, 25:11-17.
9. Bergh C, Eriksson M, Lindberg G, et al.: Selective serotonin reuptake inhibitors in anorexia. Lancet 1996, 348:1459-1460.
10. Practice guideline for the treatment of patients with eating disorders. http://www.psych.org/clin_res/guide.bk42301.cfm.Accessed April 2, 2003.
11. Kaye WH, Nagata T, Weltzin TE, et al.: Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry 2000, 49:644-652.
12. Bergh C, Södersten P: Anorexia nervosa, self-starvation and the reward of stress. Nat Med 1996, 2:21-22.
13. Bergh C, Brodin U, Lindberg G, et al.: Randomized controlled trial of a treatment for anorexia and bulimia nervosa. Proc Natl Acad Sci USA 2002, 99:9486-9491.
14. Gull WW: Anorexia nervosa (apepsia hysterica, anorexia hysterica). Trans Clin Soc London 1874, 7:22-28.
15. Morrow NS, Schall M, Grijalva CV, et al.: Body temperature and wheel running predict survival times in rats exposed to activity-stress. Physiol Behav 1997, 62:815-25.
16. Gutierrez E, Vazquez R: Heat in the treatment of patients with anorexia nervosa. Eat Weight Disord 2001, 6:49-52.